Health TrialsbyHealthPanel

Community Partnership for Telehealth Solutions to Convey Information and Enhance Care

ConditionColorectal Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-64
SponsorUniversity of Arizona

About this trial

Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ages 45-64

Eligible for colorectal cancer (CRC) screening

Current patients (seen in the clinic in the last 6 months)

Primary speaker of English or Spanish

Disqualifiers

Colorectal disease (e.g., ulcerative colitis or colectomy)

Personal history of colorectal cancer

End-stage or life-threatening diseases

Known to be under hospice care

Trial design

Design model

Sequential

Treatments tested in this trial

  • Video text message

    Behavioral

    Video text messages tailored to the Latinx population to educate and motivate patients to complete CRC screening.

  • In-clinic CRC screening promotion

    Behavioral

    Stool-test orders, colonoscopy referrals.

  • Mailed FIT

    Behavioral

    Mailed FIT kits.

  • Social needs navigation

    Behavioral

    Patient navigation to address social needs.

  • Reminders

    Behavioral

    Centralized text and/or telephone reminders for ordered tests.

Treatment groups

6,000 Participants
are divided into 2 treatment groups
Group A: Video text message, mailed FIT, and social needs navigationExperimental treatment 3 interventions
Group B: Usual careActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

CRC Screening Completion at the Individual Level

Measure the completion rate of colorectal cancer (CRC) screening at the individual level within 6 months of receiving the intervention. This will compare the proportion of participants in the post-intervention group versus the pre-intervention group.

Time frame
6 months

Secondary outcomes

1

FIT completion

Measure the completion rate of fecal immunochemical tests (FIT) within 6 months of receiving the intervention. This will compare the proportion of participants who complete FIT in the post-intervention group versus the pre-intervention group.

Time frame
6 months
2

Rate of Follow-Up Colonoscopy Completion

Track the completion rate of follow-up colonoscopy within 12 months for participants with abnormal FIT results, comparing the post-intervention versus pre-intervention groups.

Time frame
12 months
3

Time to follow-up colonoscopy

Measure the time from abnormal FIT result to the completion of follow-up colonoscopy, comparing the post-intervention versus the pre-intervention groups.

Time frame
Within 12 months post abnormal FIT result

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Arizona

Lead sponsor

San Diego State University

Collaborator

AltaMed Health Services Corporation

Collaborator

Kaiser Permanente

Collaborator

Source ClinicalTrials.gov
Apply now